SK Bioscience Reports Third-Quarter Net Loss Amid Revenue Decline

Seoul: SK Bioscience Co. reported a net loss of 22.3 billion won (US$16.2 million) for the third quarter, a reversal from the 48.4 billion won profit recorded in the same period last year. The announcement underscores the challenges faced by the company amid a significant drop in sales. According to Yonhap News Agency, SK Bioscience's regulatory filing revealed an operating loss of 39.6 billion won for the July-September period, compared to an operating profit of 60.9 billion won a year earlier. The company's sales also took a hit, plummeting 73.4 percent to 61.6 billion won. The financial performance marks a challenging period for SK Bioscience as it navigates a sharp decline in revenue and profitability. The company has not disclosed specific factors contributing to the downturn, leaving stakeholders to assess the broader market and operational conditions affecting its performance.